Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-24

Clinical Trial Update: Limiting Chemotherapy Side Effects by Using Moxa [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating whether moxa (moxibustion) can limit chemotherapy-related side effects in patients with breast or colorectal cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxa (moxibustion)

Snippet

Sponsor: East and North Hertfordshire NHS Trust | Conditions: Breast Neoplasms, Colorectal Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN